Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a new MeSH term 'Primary interstitial lung disease specific to childhood' and a Genetic and Rare Diseases Information Center resources link to the study page.
    Difference
    0.1%
    Check dated 2026-04-03T05:57:45.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T23:50:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-03-12T20:53:44.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-12T05:21:58.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A minor revision tag was updated from v3.4.0 to v3.4.1; there is no evidence of substantive changes to study content or function. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T03:49:21.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata with Revision: v3.4.0, including capitalization changes to QC status labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T00:00:40.000Z thumbnail image

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.